The effect of baseline testosterone on the efficacy of degarelix and leuprolide: further insights from a 12-month, comparative, phase III study in prostate cancer patients

Jan-Erik Damber; Teuvo L J Tammela; Peter Iversen; Per-Anders Abrahamsson; Laurent Boccon-Gibod; Tine Kold Olesen; Egbert van der Meulen; Bo-Eric Persson

doi:10.1016/j.urology.2012.01.092

The effect of baseline testosterone on the efficacy of degarelix and leuprolide: further insights from a 12-month, comparative, phase III study in prostate cancer patients

Jan-Erik Damber, Teuvo L J Tammela, Peter Iversen, Per-Anders Abrahamsson, Laurent Boccon-Gibod, Tine Kold Olesen, Egbert van der Meulen, Bo-Eric Persson

24 Citations (Scopus)

Abstract

To investigate the effects of baseline testosterone on testosterone control and prostate-specific antigen (PSA) suppression using data from a phase III trial (CS21) comparing degarelix and leuprolide in prostate cancer.

Original language	English
Journal	Urology
Volume	80
Issue number	1
Pages (from-to)	174-80
Number of pages	7
ISSN	0090-4295
DOIs	https://doi.org/10.1016/j.urology.2012.01.092
Publication status	Published - 2012

Keywords

Aged
Antineoplastic Agents, Hormonal
Gonadotropin-Releasing Hormone
Humans
Leuprolide
Male
Oligopeptides
Prostatic Neoplasms
Testosterone

Access to Document

10.1016/j.urology.2012.01.092

Cite this

Damber, J.-E., Tammela, T. L. J., Iversen, P., Abrahamsson, P.-A., Boccon-Gibod, L., Olesen, T. K., van der Meulen, E., & Persson, B.-E. (2012). The effect of baseline testosterone on the efficacy of degarelix and leuprolide: further insights from a 12-month, comparative, phase III study in prostate cancer patients. Urology, 80(1), 174-80. https://doi.org/10.1016/j.urology.2012.01.092

Damber, J-E, Tammela, TLJ, Iversen, P, Abrahamsson, P-A, Boccon-Gibod, L, Olesen, TK, van der Meulen, E & Persson, B-E 2012, 'The effect of baseline testosterone on the efficacy of degarelix and leuprolide: further insights from a 12-month, comparative, phase III study in prostate cancer patients', Urology, vol. 80, no. 1, pp. 174-80. https://doi.org/10.1016/j.urology.2012.01.092

@article{25896a58201f4d5795dfde19dd19e243,

title = "The effect of baseline testosterone on the efficacy of degarelix and leuprolide: further insights from a 12-month, comparative, phase III study in prostate cancer patients",

abstract = "To investigate the effects of baseline testosterone on testosterone control and prostate-specific antigen (PSA) suppression using data from a phase III trial (CS21) comparing degarelix and leuprolide in prostate cancer.",

keywords = "Aged, Antineoplastic Agents, Hormonal, Gonadotropin-Releasing Hormone, Humans, Leuprolide, Male, Oligopeptides, Prostatic Neoplasms, Testosterone",

author = "Jan-Erik Damber and Tammela, {Teuvo L J} and Peter Iversen and Per-Anders Abrahamsson and Laurent Boccon-Gibod and Olesen, {Tine Kold} and {van der Meulen}, Egbert and Bo-Eric Persson",

year = "2012",

doi = "10.1016/j.urology.2012.01.092",

language = "English",

volume = "80",

pages = "174--80",

journal = "Urology",

issn = "0090-4295",

publisher = "Excerpta Medica, Inc",

number = "1",

}

TY - JOUR

T1 - The effect of baseline testosterone on the efficacy of degarelix and leuprolide

T2 - further insights from a 12-month, comparative, phase III study in prostate cancer patients

AU - Damber, Jan-Erik

AU - Tammela, Teuvo L J

AU - Iversen, Peter

AU - Abrahamsson, Per-Anders

AU - Boccon-Gibod, Laurent

AU - Olesen, Tine Kold

AU - van der Meulen, Egbert

AU - Persson, Bo-Eric

PY - 2012

Y1 - 2012

N2 - To investigate the effects of baseline testosterone on testosterone control and prostate-specific antigen (PSA) suppression using data from a phase III trial (CS21) comparing degarelix and leuprolide in prostate cancer.

AB - To investigate the effects of baseline testosterone on testosterone control and prostate-specific antigen (PSA) suppression using data from a phase III trial (CS21) comparing degarelix and leuprolide in prostate cancer.

KW - Aged

KW - Antineoplastic Agents, Hormonal

KW - Gonadotropin-Releasing Hormone

KW - Humans

KW - Leuprolide

KW - Male

KW - Oligopeptides

KW - Prostatic Neoplasms

KW - Testosterone

U2 - 10.1016/j.urology.2012.01.092

DO - 10.1016/j.urology.2012.01.092

M3 - Journal article

C2 - 22748873

SN - 0090-4295

VL - 80

SP - 174

EP - 180

JO - Urology

JF - Urology

IS - 1

ER -

The effect of baseline testosterone on the efficacy of degarelix and leuprolide: further insights from a 12-month, comparative, phase III study in prostate cancer patients

Abstract

Keywords

Access to Document

Fingerprint

Cite this